Deutsche Bank’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
107,716
-26,702
| -20% | -$61.7K | ﹤0.01% | 2834 |
|
|
2025
Q1 | $187K | Sell |
134,418
-16,665
| -11% | -$23.2K | ﹤0.01% | 2955 |
|
|
2024
Q4 | $261K | Sell |
151,083
-2,409,201
| -94% | -$4.17M | ﹤0.01% | 2941 |
|
|
2024
Q3 | $5.15M | Buy |
2,560,284
+22,936
| +0.9% | +$46.1K | ﹤0.01% | 1257 |
|
|
2024
Q2 | $5.68M | Buy |
+2,537,348
| New | +$5.68M | ﹤0.01% | 1189 |
|
|
2022
Q2 | – | Sell |
-12,366
| Closed | -$81K | – | 4129 |
|
|
2022
Q1 | $81K | Sell |
12,366
-1,458
| -11% | -$9.55K | ﹤0.01% | 3603 |
|
|
2021
Q4 | $161K | Buy |
13,824
+716
| +5% | +$8.34K | ﹤0.01% | 3441 |
|
|
2021
Q3 | $244K | Sell |
13,108
-414
| -3% | -$7.71K | ﹤0.01% | 3434 |
|
|
2021
Q2 | $286K | Buy |
13,522
+7,670
| +131% | +$162K | ﹤0.01% | 3544 |
|
|
2021
Q1 | $119K | Sell |
5,852
-237
| -4% | -$4.82K | ﹤0.01% | 3831 |
|
|
2020
Q4 | $162K | Buy |
+6,089
| New | +$162K | ﹤0.01% | 3521 |
|